How does calorie restriction work?

J Koubova, L Guarente - Genes & development, 2003 - genesdev.cshlp.org
J Koubova, L Guarente
Genes & development, 2003genesdev.cshlp.org
For almost 70 years, calorie restriction has been known to extend life span. Despite the
extensive physiological characterization of this dietary regimen, the molecular basis for the
slowing in aging remains unsolved. Recent findings have pinpointed a few molecular
pathways that appear to regulate the aging process. In this review, we propose a molecular
model for how calorie restriction works that incorporates these recent findings. Calorie
restriction (CR) refers to a dietary regimen low in calories without undernutrition. It was first …
For almost 70 years, calorie restriction has been known to extend life span. Despite the extensive physiological characterization of this dietary regimen, the molecular basis for the slowing in aging remains unsolved. Recent findings have pinpointed a few molecular pathways that appear to regulate the aging process. In this review, we propose a molecular model for how calorie restriction works that incorporates these recent findings. Calorie restriction (CR) refers to a dietary regimen low in calories without undernutrition. It was first noted in the 1930s that food restriction significantly extends the life span of rodents (McCay et al. 1935). This longevity results from the limitation of total calories derived from carbohydrates, fats, or proteins to a level 25%–60% below that of control animals fed ad libitum (Richardson 1985; Weindruch et al. 1986). The extension in life span can approach 50% in rodents (Sohal and Weindruch 1996). CR extends life span in a remarkable range of organisms, including yeast, rotifers, spiders, worms, fish, mice, and rats (Weindruch and Walford 1988). Emerging data show that its effect may also apply to nonhuman primates (Lane et al. 2001). CR delays a wide spectrum of diseases in different experimental animals; for example, kidney disease, a variety of neoplasias, autoimmune disease, and diabetes (Fernandes et al. 1976; Sarkar et al. 1982; Fernandes and Good 1984; Kubo et al. 1984; Engelman et al. 1990; Shields et al. 1991; Johnson et al. 1997). CR reduces ageassociated neuronal loss in most mouse models of neurodegenerative disorders such as Parkinson’s disease (Duan and Mattson 1999) or Alzheimer’s disease (Zhu et al. 1999). However, beneficial effects in a mouse model for amyotrophic lateral sclerosis were not observed (Pedersen and Mattson 1999). The CR regimen also prevents age-associated declines in psychomotor and spatial memory tasks (Ingram et al. 1987) and loss of dendritic spines necessary for learning (Moroi-Fetters et al. 1989) and improves the brain’s plasticity and ability for selfrepair (Mattson 2000).
genesdev.cshlp.org